Balaxi Pharmaceuticals Ltd
NSE:BALAXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Balaxi Pharmaceuticals Ltd
Other
Balaxi Pharmaceuticals Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
|
Other
-₹53.4m
|
CAGR 3-Years
-150%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Kretto Syscon Ltd
BSE:531328
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
Dipna Pharmachem Ltd
BSE:543594
|
Other
-₹20.2m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hemant Surgical Industries Ltd
BSE:543916
|
Other
-₹21.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
A
|
Achyut Healthcare Ltd
BSE:543499
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Balaxi Pharmaceuticals Ltd
Glance View
Balaxi Pharmaceuticals Ltd. engages in the exportation of pharmaceutical, hardware, and FMCG products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2015-11-30. The Company’s products include Nice 45 G, Guloso 45 G, Snax! 42 G, Doce E Sal 42 G, Yumm 75 G and Boadent. The firm is offerings more than 300 products across multiple therapeutic areas, including Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steriod, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhoea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents and Laxative.
See Also
What is Balaxi Pharmaceuticals Ltd's Other?
Other
-53.4m
INR
Based on the financial report for Dec 31, 2025, Balaxi Pharmaceuticals Ltd's Other amounts to -53.4m INR.
What is Balaxi Pharmaceuticals Ltd's Other growth rate?
Other CAGR 3Y
-150%
Over the last year, the Other growth was -5 462%. The average annual Other growth rates for Balaxi Pharmaceuticals Ltd have been -150% over the past three years .
